{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:41:45Z","timestamp":1792212105256,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.coi.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T16:48:05Z","timestamp":1476722885000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Understanding mechanisms of autoimmunity through translational research in vitiligo"],"prefix":"10.1016","volume":"43","author":[{"given":"James P","family":"Strassner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2016.09.008_bib0355","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.coi.2016.09.008_bib0360","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2016.09.008_bib0365","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2015.07.039","article-title":"Vitiligo working group: vitiligo is not a cosmetic disease","volume":"73","author":"Ezzedine","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0370","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2016.09.008_bib0375","first-page":"343","article-title":"Interfering with the IFN-gamma\/CXCL10 pathway to develop new targeted treatments for vitiligo","volume":"3","author":"Rashighi","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.coi.2016.09.008_bib0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2133.1968.tb12282.x","article-title":"Vitiligo, thyroid disease and autoimmunity","volume":"80","author":"Cunliffe","year":"1968","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0385","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1346-8138.12147","article-title":"Modern vitiligo genetics sheds new light on an ancient disease","volume":"40","author":"Spritz","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0390","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigement Cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0395","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_sbref0400","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1073\/pnas.1525001113","article-title":"Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A * 02: 01 in vivo","volume":"113","author":"Hayashi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2016.09.008_sbref0405","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1073\/pnas.1523482113","article-title":"MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo","volume":"113","author":"Cavalli","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2016.09.008_bib0410","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.1222808110","article-title":"NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1beta processing via the NLRP1 inflammasome","volume":"110","author":"Levandowski","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2016.09.008_bib0415","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm199","article-title":"The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma","volume":"2","author":"Spritz","year":"2010","journal-title":"Genome Med"},{"key":"10.1016\/j.coi.2016.09.008_bib0420","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.4049\/jimmunol.174.11.6863","article-title":"Sequential immune escape and shifting of T Cell responses in a long-term survivor of melanoma","volume":"174","author":"Yamshchikov","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2016.09.008_bib0425","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2016.09.008_bib0430","doi-asserted-by":"crossref","first-page":"e1000523","DOI":"10.1371\/journal.pgen.1000523","article-title":"Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo","volume":"5","author":"Ren","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.coi.2016.09.008_bib0435","doi-asserted-by":"crossref","first-page":"7448","DOI":"10.1128\/MCB.23.21.7448-7459.2003","article-title":"Xbp-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response","volume":"23","author":"Lee","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coi.2016.09.008_bib0440","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coi.2016.09.008_bib0445","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.cell.2008.07.021","article-title":"XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease","volume":"134","author":"Kaser","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.coi.2016.09.008_bib0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12369","article-title":"Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo","volume":"269","author":"Harris","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2016.09.008_bib0455","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1016\/j.coi.2016.09.008_bib0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12480976","article-title":"Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes","volume":"97","author":"Boissy","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0465","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1523-1747.ep12469795","article-title":"In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects","volume":"88","author":"Puri","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0470","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00456389","article-title":"Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro","volume":"281","author":"Puri","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0475","first-page":"441","article-title":"Successful culture of adult human melanocytes obtained from normal and vitiligo donors","volume":"95","author":"Medrano","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0480","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0485","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-0749.2001.140303.x","article-title":"Redox regulation in human melanocytes and melanoma","volume":"14","author":"Meyskens","year":"2001","journal-title":"Pigment cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0490","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0495","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.1939.72800350003010a","article-title":"Occupational leukoderma","volume":"113","author":"Oliver","year":"1937","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.coi.2016.09.008_bib0500","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0505","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/jid.2011.16","article-title":"Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy","volume":"131","author":"van den Boorn","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0510","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1523-1747.2000.00836.x","article-title":"The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity","volume":"114","author":"Yang","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0515","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0520","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0525","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pcmr.12208","article-title":"Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress","volume":"27","author":"Mosenson","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_sbref0530","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.immuni.2016.05.008","article-title":"Inflammasome-dependent induction of adaptive NK memory","volume":"44","author":"van den Boorn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2016.09.008_bib0535","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coi.2016.09.008_bib0540","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients","volume":"80","author":"van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.coi.2016.09.008_bib0545","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2016.09.008_bib0550","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.coi.2016.09.008_bib0555","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0560","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2016.09.008_bib0565","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-y for autoreactive CD8+ T cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0570","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0575","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2016.09.008_sbref0580","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2016.09.008_bib8585","article-title":"Keratinocyte-derived chemokines orchestrate T cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease","author":"Richmond","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0585","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don\u2019t know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coi.2016.09.008_bib0590","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0595","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0600","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0605","first-page":"1110","article-title":"Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"J Am Med Assoc Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_sbref0610","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaad.2015.09.073","article-title":"Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)","volume":"74","author":"Harris","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0615","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/jid.2011.41","article-title":"Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita","volume":"131","author":"Zhao","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0620","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-3-7","article-title":"Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo","volume":"3","author":"No\u00ebl","year":"2004","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.coi.2016.09.008_bib0625","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/jid.2014.529","article-title":"Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo","volume":"135","author":"Agarwal","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0630","doi-asserted-by":"crossref","first-page":"es1040","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional Skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2016.09.008_bib0635","doi-asserted-by":"crossref","first-page":"174ra28","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2016.09.008_bib0640","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00493","article-title":"FOXP3+ Treg cells and its gender bias in autoimmune diseases","volume":"6","author":"Nie","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2016.09.008_bib0645","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.13511","article-title":"Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation","volume":"172","author":"Tembhre","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2016.09.008_bib0650","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2013.05.005","article-title":"T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo","volume":"424","author":"Tembhre","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.coi.2016.09.008_bib0655","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4+\/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0660","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2016.09.008_bib0665","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1755-148X.2012.01019.x","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0670","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","article-title":"Levels of TGF-\u03b21 in serum and culture supernatants of CD4+ CD25+ T cells from patients with non-segmental vitiligo","volume":"303","author":"Tu","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.coi.2016.09.008_bib0675","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.coi.2016.09.008_sbref0680","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.aaa1292","article-title":"Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals","volume":"346","author":"Maeda","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.coi.2016.09.008_bib0685","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.immuni.2011.06.005","article-title":"Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper responses","volume":"35","author":"Igy\u00e1rt\u00f3","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2016.09.008_bib0690","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.immuni.2015.01.008","article-title":"Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation","volume":"42","author":"Kashem","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2016.09.008_bib0695","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.20091964","article-title":"CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells","volume":"207","author":"Henri","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2016.09.008_bib0700","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791516301091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791516301091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:32:25Z","timestamp":1760603545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791516301091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":71,"alternative-id":["S0952791516301091"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2016.09.008","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding mechanisms of autoimmunity through translational research in vitiligo","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}